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CLINICAL RESEARCH ARTICLE
Active duty and ex-serving military personnel with post-traumatic stress
disorder treated with psychological therapies: systematic review and
meta-analysis
Neil J. Kitchiner a,b, Catrin Lewis b, Neil P. Roberts a,b and Jonathan I. Bisson b
aDepartment of Psychology and Psychological Therapies, Cardiff and Vale University Health Board, Cardiff, UK; bDivision of Psychological
Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK
ABSTRACT
Background: Post-traumatic stress disorder (PTSD) is a major cause of morbidity amongst
active duty and ex-serving military personnel. In recent years increasing efforts have been
made to develop more effective treatments.
Objective: To determine which psychological therapies are efficacious in treating active
duty and ex-serving military personnel with post-traumatic stress disorder (PTSD).
Method: A systematic review was undertaken according to Cochrane Collaboration
Guidelines. The primary outcome measure was reduction in PTSD symptoms and the
secondary outcome dropout.
Results: Twenty-four studies with 2386 participants were included. Evidence demonstrated
that CBT with a trauma focus (CBT-TF) was associated with the largest evidence of effect
when compared to waitlist/usual care in reducing PTSD symptoms post treatment (10
studies; n = 524; SMD −1.22, −1.78 to −0.66). Group CBT-TF was less effective when
compared to individual CBT-TF at reducing PTSD symptoms post treatment (1 study;
n = 268; SMD −0.35, −0.11 to −0.59). Eye Movement Desensitization and Reprocessing
(EMDR) therapy was not effective when compared to waitlist/usual care at reducing PTSD
symptoms post treatment (4 studies; n = 92; SMD −0.83, −1.75 to 0.10). There was evidence
of greater dropout from CBT-TF therapies compared to waitlist and Present Centred
Therapy.
Conclusions: The evidence, albeit limited, supports individual CBT-TF as the first-line psy-
chological treatment of PTSD in active duty and ex-serving personnel. There is evidence for
Group CBT-TF, but this is not as strong as for individual CBT-TF. EMDR cannot be recom-
mended as a first line therapy at present and urgently requires further evaluation. Lower
effect sizes than for other populations with PTSD and high levels of drop-out suggest that
CBT-TF in its current formats is not optimally acceptable and further research is required to
develop and evaluate more effective treatments for PTSD and complex PTSD in active duty
and ex-serving military personnel.
Personal militar en servicio activo y en retiro, con trastorno de estrés
postraumático tratado con terapias psicológicas: revisión sistemática
y metanálisis.
Antecedentes: el trastorno de estrés postraumático (TEPT) es una causa importante de morbi-
lidad entre el personal militar activo y en retiro. En los últimos años se han realizado esfuerzos
crecientes para desarrollar tratamientos más efectivos.
Objetivo: determinar qué terapias psicológicas son eficaces en el tratamiento del personal
militar en servicio activo y en retiro con trastorno de estrés postraumático (TEPT).
Método: se realizó una revisión sistemática de acuerdo con las Pautas de la Colaboración
Cochrane. La medida de resultado primaria fue la reducción de los síntomas de TEPT y la
secundaria los abandonos al tratamiento.
Resultados: se incluyeron 24 estudios con 2386 participantes. La evidencia demostró que la
Terapia cognitivo conductual centrada en el trauma (TCC-CT) se asoció con la mayor
evidencia de efecto en comparación con la lista de espera/atención habitual en la
reducción de los síntomas de TEPT después del tratamiento (10 estudios; n = 524; DME
-1.22, -1.78 a - 0,66). La TCC-CT grupal fue menos efectivo en comparación con el TCC-CT
individual para reducir los síntomas de TEPT después del tratamiento (1 estudio; n = 268;
SMD -0.35, -0.11 a -0.59). La terapia de desensibilización y reprocesamiento por movimiento
ocular (EMDR) no fue efectiva en comparación con la lista de espera/atención habitual para
reducir los síntomas de TEPT después del tratamiento (4 estudios; n = 92; SMD -0.83, -1.75
a 0.10). Hubo evidencia de un mayor abandono de las terapias TCC-CT en comparación con
la lista de espera y la terapia centrada en el presente.
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HIGHLIGHTS
• PTSD is a common
psychiatric condition
amongst active duty and ex-
serving military personnel.
• Evidence supports
individual CBT-TF as the
first-line psychological
treatment of PTSD in active
duty and ex-serving
personnel.
• High levels of drop-out
suggest that CBT-TF in its
current formats of delivery is
not optimally acceptable to
active duty and ex-serving
military personnel.
• EMDR currently cannot be
recommended as a first line
therapy for active duty and
ex-serving military
personnel and further
evaluation is urgently
required.
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Conclusiones: La evidencia, aunque limitada, respalda la TCC-CT individual como el trata-
miento psicológico de primera línea del TEPT en el personal militar en servicio activo y en
retiro. Existe evidencia de TCC-CT grupal, pero esta no es tan consistente como para TCC-CT
individual. No se puede recomendar EMDR como terapia de primera línea en la actualidad
y requiere urgentemente una evaluación adicional. Los tamaños de efecto más bajos que
para otras poblaciones con TEPT y altos niveles de abandono sugieren que TCC-TC en sus
formatos actuales no es óptimamente aceptable y se requiere más investigación para
desarrollar y evaluar tratamientos más efectivos para TEPT y TEPT complejo en personal
militar en servicio activo y en retiro.
采用心理疗法治疗的创伤后应激障碍现役和退役军人：系统综述和元分
析。
背景：创伤后应激障碍（PTSD）是现役和退役军人的一个主要发病原因。近年来，越来
越多的努力投入到开发更有效的治疗方法中。
目的：确定哪种心理疗法可有效治疗患有创伤后应激障碍（PTSD）的现役和退役军人。
方法：系统综述依据Cochrane协作指南进行。主要测量指标是PTSD症状的减轻，次要结
果是脱落情况。
结果：入组共24项研究, 2386名参与者。有证据表明，相较于候补/常规护理，聚焦创伤的
CBT（CBT-TF）减轻治疗后PTSD症状的实证效应最大（10项研究； n= 524； SMD -1.22，-
1.78至- 0.66）。团体CBT-TF相较于个体CBT-TF在减轻治疗后PTSD症状的效果上较差（1项
研究； n= 268； SMD -0.35，-0.11至-0.59）。与候补/常规护理相比，眼动脱敏再处理
（EMDR）疗法在减轻治疗后PTSD症状方面无效（4项研究； n= 92； SMD -0.83，-1.75至
0.10）。有证据表明，与候补和聚焦当下疗法相比，CBT-TF治疗的退出率更高。
结论：证据虽然有限，但仍支持将个体CBT-TF作为现役和退役人员PTSD的一线心理治疗
方法。也有团体CBT-TF的实证证据，但不如个体CBT-TF的有力。目前EMDR尚不推荐作为
一线治疗，并且迫切需要进一步评估。相较于其他PTSD患者和高流失水平，较低的效应
量和较高的退出率表明，当前形式的CBT-TF并非最佳选择，需要进一步研究以开发和评估
针对现役和退役人员PTSD更有效的治疗方法。
1. Introduction
Post-traumatic stress disorder (PTSD) is a common psy-
chiatric condition amongst active duty and ex-serving
military personnel across the world, creating
a significant public health challenge (Steenkamp, Litz,
Hoge, &Marmar, 2015). For reasons that are not entirely
clear, prevalence rates vary between nations with
reported rates of 20 to 30% (Richardson, Frueh, &
Acierno, 2010) in US troops returning from various con-
flicts from the Vietnam era through to the present day,
6% to 17% in the UK (Stevelink et al., 2018), 5% in
Canada (Richardson et al., 2019), and 3% in the
Netherlands (Engelhard et al., 2007).
Over the past three decades there has been consider-
able investment in new treatment models and evalua-
tion of them, leading to advances in the treatment of
PTSD in civilian and military populations (Carlson,
Chemtob, Rusnak, Hedlund, & Muraoka, 1998; Foa
et al., 2018; Resick et al., 2015; Steenkamp et al., 2015;
Tylee, Gray, Glatt, & Bourke, 2017). International clin-
ical practice guidelines unanimously recommend
trauma focused psychological therapies (TFPT) in the
form of Eye Movement Desensitization Reprocessing
(EMDR), and individual Cognitive Behavioural
Therapy with a trauma focus (CBT-TF) as first line
treatments for PTSD. Cognitive Processing Therapy
(CPT), Cognitive Therapy with a trauma focus and
Prolonged Exposure (PE) are specific CBT-TFs with
enough evidence to merit recommendation as first line
treatments in their own right (International Society of
Traumatic Stress Studies [ISTSS], 2018, NICE, 2018).
Previous work has suggested that the efficacy of estab-
lished trauma focused interventions benefit less in ser-
ving and ex-serving personnel (Haagen, Smid,
Knipscheer, & Kleber, 2015; Kitchiner, Roberts,
Wilcox, & Bisson, 2012).
The US Department of Defence (2017) guide-
lines on PTSD recommend out-patient trauma
focused psychological therapies (TFPT) before
pharmacological interventions or other forms of
therapy due to the benefits of TFPT being longer-
lived (Ostacher & Cifu, 2019). Interestingly, the UK
NICE PTSD guidelines (2018) also recommend
TFPT as a first line of therapy, but not EMDR for
combat-related trauma due to the current evidence
base (NICE, 2018). Steenkamp has criticized the
current DoD/VA PTSD treatment guidelines as
based primarily on studies with civilian samples,
with traumas very different to military deployment
and, therefore, findings that may not translate to
active duty and ex-serving military personnel
(Steenkamp et al., 2015). Our 2012 review identi-
fied 16 PTSD treatment randomized controlled
trials (RCTs) with ex-service personnel but only
four studies of TFPTs for PTSD had data available
for meta-analysis (Kitchiner et al., 2012). These
four studies were heterogeneous and included
EMDR and CBT-TF interventions which, together,
were more effective at reducing PTSD symptoms
post treatment than treatment as usual or waitlist,
(n = 128; SMD −0.59, 95% CI −1.09, −0.10)
(Carlson et al., 1998; Devilly, Spence, & Rapee,
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1998; Keane, Fairbank, Caddell, & Zimering, 1989;
Monson et al., 2006). The completion of a number
of studies since 2012 means that it is timely to
update the evidence base for treating PTSD in
active duty and ex-serving military personnel.
There is a growing literature on efforts to improve
the treatment of PTSD in ex-serving and, more
recently, active duty personnel. These include novel
therapies which use glasses that track REM sleep and
play music (Ahmadi, Hazrati, Ahmadizadeh, & Noohi,
2015), multi-modular motion assisted memory desen-
sitization reconsolidation (3MDR) using a treadmill,
music and images combined with virtual reality
(Nijdam & Vermetten, 2018; van Gelderen, Nijdam,
& Vermetten, 2018), PE with virtual reality (Gamito
et al., 2010; McLay et al., 2017, 2011), neuro-linguistic
programming (NLP) informed exposure based therapy
(Gray, Budden-Potts, & Bourke, 2017; Tylee et al.,
2017), couples therapy (Sautter, Glynn, Cretu,
Senturk, & Vaught, 2015) and intensive PE (Foa
et al., 2018). Our aim was to update the current evi-
dence base by undertaking a systematic review and
meta-analysis of psychological therapy RCTs for the
treatment of active duty or ex-serving military person-
nel with PTSD. We also sought to investigate possible
reasons why the benefits from therapy for this popula-
tion might differ from those observed in civilian popu-
lations (NICE, 2018; Steenkamp et al., 2015).
2. Method
2.1. Selection criteria
This review included RCTs of any defined psycholo-
gical therapy aimed at the reduction of PTSD symp-
toms in active duty and ex-serving personnel, in
comparison with a control group (e.g. usual care/
waiting list), other psychological therapy or psycho-
social intervention (e.g. psychoeducation/relaxation
training). It was required that 70% of study partici-
pants were diagnosed with PTSD with a duration of
three months or more, according to DSM or ICD
criteria determined by clinician diagnosis or an estab-
lished diagnostic interview. Only studies of adults
aged 18 or over were eligible. There were no restric-
tions based on symptom severity or trauma type. The
diagnosis of PTSD was required to be primary, but
there were no other exclusions based on comorbidity.
Studies that conducted secondary analyses of data
already included in the meta-analyses were excluded.
Studies were also excluded if a continuous measure of
PTSD severity post-treatment was not available. The
initial searches identified 5500 potentially eligible
studies. Abstracts were reviewed and full text copies
obtained for 203 potentially relevant studies. This
resulted in 114 RCTs that were included in an
updated review of psychological treatment for
PTSD, irrespective of trauma type (Lewis et al, in
preparation). Of these, there were 24 RCTs of active
duty of ex-serving military personnel with PTSD (see
Figure 1) with 2386 participants, which allowed for
several meta-analyses of the data.
2.2. Search strategy
This systematic review was undertaken alongside
a number of reviews for an update of the
International Society for Traumatic Stress Studies
(ISTSS) Treatment Guidelines (ISTSS, 2018).
A search was conducted by the Cochrane
Collaboration, which updated a previously published
Cochrane review with similar inclusion criteria, which
was published in 2013 (Bisson, 2013). The update
search aimed to identify all RCTs related to the pre-
vention and treatment of PTSD, published from 2008
to the 31 May 2018. We searched through all included
studies evaluating a psychological intervention in
active duty and ex-serving military personnel, which
provided a final group of papers included in this
review. The searches included results from PubMed,
PsycINFO, Embase and the Cochrane database of ran-
domized trials. Terms related to PTSD were combined
with terms referring to psychological therapy (using
both MeSH terms and text words). We checked refer-
ence lists of the included studies. We searched the
World Health Organization’s, and the U.S. National
Figure 1. Flow diagram for study selection.
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Institutes of Health’s trials portals to identify additional
unpublished or ongoing studies. We contacted experts
in the field with the aim of identifying unpublished
studies and studies that were in submission.
A complementary search of the Published
International Literature on Traumatic Stress
(PILOTS) was also conducted. The updated search
aimed to identify all RCTs related to the prevention
and treatment of PTSD, published from January 2008
to the 31 May 2018, using the search terms PTSD or
posttrauma* or post-trauma* or ‘post trauma*’ or
‘combat disorder*’ or ‘stress disorder*’. The searches
included results from PubMed, PsycINFO, Embase
and the Cochrane database of randomized trials. This
produced a group of papers related to the psychological
treatment of PTSD in adults.
2.3. Data extraction
Study characteristics and outcome data were
extracted by two reviewers, using a form that had
been piloted on five of the included studies. The
primary outcome measure for the review was reduc-
tion in the severity of PTSD symptoms post treat-
ment using a standardized measure. When available,
clinician rated measures were included in meta-
analyses (e.g. the Clinician Administered PTSD
Scale (CAPS) (Blake et al., 1995)). If no clinician
rated measure was used or reported, self-report mea-
sures were included (e.g. the PTSD Checklist for
DSM-5 (PCL-5) (Weathers et al., 2013)). Study
authors were contacted to obtain missing data.
2.4. Risk of bias assessment
All included studies were assessed for risk of bias using
Cochrane criteria (Higgins et al., 2011). This included:
(1) sequence allocation for randomization (the meth-
ods used for randomly assigning participants to the
treatment arms and the extent to which this was truly
random); (2) allocation concealment (whether or not
participants or personnel were able to foresee alloca-
tion to a specific group); (3) assessor blinding (whether
the assessor was aware of group allocation); (4) incom-
plete outcome data (whether missing outcome data
was handled appropriately); (5) selective outcome
reporting (whether reported outcomes matched with
those that were pre-specified); and (6) any other nota-
ble threats to validity (for example, baseline imbal-
ances between groups, small sample size, or
premature termination of the study). Two researchers
independently assessed each study and any conflicts
were discussed with a third researcher with the aim of
reaching a unanimous decision.
2.5. Clinical importance, quality of evidence
assessment and level of recommendation
We rated findings in terms of clinical importance.
We used a definition of clinical importance, which
was developed by the ISTSS Treatment Guidelines
Committee and approved by the ISTSS Board and
membership (Bisson, Berliner, Cloitre, & Forbes
et al., in press), building on previous work by the
National Institute of Health and Care Excellence
(National Collaborating Centre for Mental, 2005).
To be rated clinically important, an intervention
had to demonstrate an effect size of >0.8 for con-
tinuous outcomes for wait list and treatment as
usual (TAU) control comparisons, >0.4 for placebo
control comparisons and >0.2 for active treatment
control comparisons. The quality of evidence for
each comparison was assessed using the: Grading
of Recommendations Assessment, Development and
Evaluation (GRADE) system (GRADE, 2018) (see
Table 2). Evidence was categorized as high quality
(indicating that further research is very unlikely to
change confidence in the estimate of effect); moder-
ate quality (indicating that further research is likely
to have an important impact on our confidence in
the estimate of effect and may change the estimate);
low quality (indicating that further research is very
likely to have an important impact on our confi-
dence in the estimate of effect and is likely to
change the estimate) or very low quality (indicating
that we are very uncertain about the estimate). We
used the algorithm developed for ISTSS Guidelines
Committee (Weathers et al., 2013) to determine the
strength of any treatment recommendations that
could be made. The algorithm combines the clinical
importance and quality of evidence assessments
along with any other important information (e.g.
adverse effect profile).
2.6. Data synthesis
Meta-analyses were conducted using the Cochrane’s
Review Manager 5 (RevMan) software (RevMan,
2014). Continuous measures of post-treatment
PTSD severity were analysed as standardized mean
differences (SMDs). All outcomes were presented
using 95% confidence intervals. Clinical heterogene-
ity was assessed in terms of variability in the experi-
mental and control interventions; participants;
settings; and outcomes. Heterogeneity was assessed
further using both the I2 statistic and the chi-squared
test of heterogeneity, as well as visual inspection of
the forest plots. Data were pooled using fixed-effect
meta-analyses, except where heterogeneity was pre-
sent, when random-effect models were used.
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2.7. Study characteristics
Study characteristics are summarized in Table 1. Ten
studies compared CBT-TF vs. waitlist/usual care (Foa
et al., 2018; Forbes et al., 2012; Gamito et al., 2010; Gray
et al., 2017; Keane et al., 1989; McLay et al., 2011;
Monson et al., 2006; Peniston & Kulkosky, 1991;
Reger et al., 2016; Tylee et al., 2017) (see Figure 2).
These included two studies of CPT (Forbes et al.,
2012; Monson et al., 2006) (see Figure 3), two studies
of PE (Foa et al., 2018; Nacasch et al., 2011; Reger et al.,
2016) (see Figure 4), and two studies of Reconsolidation
of Traumatic Memories (RTM) (Gray et al., 2017; Tylee
et al., 2017) (see Figure 5), three studies of virtual reality
exposure (VRE) therapy vs. waitlist (Gamito et al., 2010;
McLay et al., 2011; Reger et al., 2016) (see Figure 6) and
one study compared Group CBT-TF vs. waitlist/usual
care/minimal contact (Castillo et al., 2016). Four studies
compared EMDR vs. waitlist/usual care (Ahmadi et al.,
2015; Carlson et al., 1998; Devilly et al., 1998; Jensen,
1994) (see Figure 7). Four studies comparedCBT-TF vs.
PCT (Foa et al., 2018; Rauch et al., 2015; Schnurr et al.,
2007; Suris, Link-Malcolm, Chard, Ahn, &North, 2013)
(see Figure 8). One study compared EMDR vs.
Relaxation training (Carlson et al., 1998). One study
compared EMDR vs. Rapid Eye Movement-
Desensitization (REM-D) (Ahmadi et al., 2015). Two
Figure 2. CBT-trauma focused/exposure therapy vs. waitlist/usual care.
Figure 3. Prolonged exposure vs waitlist.
Figure 4. Cognitive processing therapy vs waitlist/TAU.
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studies compared VRE therapy vs. Control Exposure
(McLay et al., 2017; Reger et al., 2016) (see Figure 9).
One study compared VRE therapy vs. PCT (Ready,
Gerardi, Backscheider, Mascaro, & Rothbaum, 2010).
Two studies compared Group CBT-TF vs. Group PCT
(Resick et al., 2015; Schnurr et al., 2003) (see Figure 10).
One study compared Group CBT-TF vs. Individual
CBT-TF (Resick et al., 2017). One study compared
Figure 5. Trauma-focused CBT/exposure therapy vs present centred therapy.
Figure 6. Group trauma-focused CBT vs group present centred therapy.
Figure 7. Virtual reality exposure therapy vs waitlist.
Figure 8. Reconsolidation of traumatic memories vs waitlist/TAU.
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Non-CBT-TF vs. Couples Psychoeducation (Sautter
et al., 2015). One study compared Relaxation training
vs. wait list/usual care (Carlson et al., 1998).
Twenty studies were conducted in the USA
(Carlson et al., 1998; Castillo et al., 2016; Foa et al.,
2018; Gray et al., 2017; Jensen, 1994; Keane et al.,
1989; McLay et al., 2017, 2011; Monson et al., 2006;
Peniston & Kulkosky, 1991; Rauch et al., 2015; Ready
et al., 2010; Reger et al., 2016; Resick et al., 2017,
2015; Sautter et al., 2015; Schnurr et al., 2007, 2003;
Suris et al., 2013; Tylee et al., 2017), two in Australia
(Devilly et al., 1998; Forbes et al., 2012), and one each
in Iran (Ahmadi et al., 2015), and Portugal (Gamito
et al., 2010). Fourteen studies included ex-serving
personnel who had left the military (Carlson et al.,
1998; Castillo et al., 2016; Devilly et al., 1998; Gamito
et al., 2010; Keane et al., 1989; Monson et al., 2006;
Nacasch et al., 2011; Peniston & Kulkosky, 1991;
Rauch et al., 2015; Ready et al., 2010; Sautter et al.,
2015; Schnurr et al., 2007, 2003; Suris et al., 2013;
Tylee et al., 2017; Yehuda et al., 2014). Six studies
contained only active duty personnel (Ahmadi et al.,
2015; McLay et al., 2017, 2011; Reger et al., 2016;
Resick et al., 2017, 2015). Two studies included
a mixture of active duty and ex-serving personnel
(Foa et al., 2018; Schnurr et al., 2007). Fifteen studies
included only males (Ahmadi et al., 2015; Carlson
et al., 1998; Devilly et al., 1998; Foa et al., 2018;
Gamito et al., 2010; Gray et al., 2017; Jensen, 1994;
Keane et al., 1989; McLay et al., 2017, 2011; Nacasch
et al., 2011; Peniston & Kulkosky, 1991; Ready et al.,
2010; Reger et al., 2016; Schnurr et al., 2003; Tylee
et al., 2017). Two studies included only females
(Castillo et al., 2016; Schnurr et al., 2007). Six studies
included both sexes (Forbes et al., 2012; Monson
et al., 2006; Rauch et al., 2015; Resick et al., 2017,
2015; Suris et al., 2013; Yehuda et al., 2014). One
study included the active duty individual and their
partner (Sautter et al., 2015). One study contained
participants who deployed to Korea (Monson et al.,
2006). Ten studies contained participants deployed to
Vietnam (Carlson et al., 1998; Devilly et al., 1998;
Forbes et al., 2012; Gray et al., 2017; Jensen, 1994;
Keane et al., 1989; Monson et al., 2006; Peniston &
Kulkosky, 1991; Ready et al., 2010; Schnurr et al.,
2003; Yehuda et al., 2014). Thirteen studies contained
participants deployed to either Iraq or Afghanistan
(Castillo et al., 2016; Foa et al., 2018; Forbes et al.,
2012; Gray et al., 2017; McLay et al., 2017, 2011;
Monson et al., 2006; Rauch et al., 2015; Reger et al.,
2016; Resick et al., 2017, 2015; Sautter et al., 2015;
Tylee et al., 2017; Yehuda et al., 2014). One study
contained participants from the Iranian war (Ahmadi
et al., 2015). One study each contained participants
who deployed to Africa (Gamito et al., 2010) and
Timor (Forbes et al., 2012). Two studies did not
Figure 9. EMDR vs waitlist/TAU.
Figure 10. Virtual reality exposure/control exposure.
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report where participants had deployed to (Schnurr
et al., 2007; Suris et al., 2013). One study reported
participants’ PTSD being due to military sexual
trauma (Suris et al., 2013). All twenty-four studies
determined PTSD diagnosis via a clinician-
administered scale.
2.8. Methodological quality of studies
Risk of bias assessments were conducted for the 24
included studies. Eight studies reported a method of
random sequence allocation judged to pose a ‘low’
risk of bias, one study a ‘high’ risk and fifteen were
‘unclear’. Allocation concealment was rated as ‘low’
risk of bias in seven studies; the remaining seventeen
were rated as ‘unclear’. Fourteen studies were judged
to have complete outcome data and ‘low’ risk of bias.
Three studies were rated as having ‘high’ risk of bias
due to incomplete data and seven as ‘unclear’.
Blinding of the outcome assessment was judged as
‘low’ risk in sixteen studies. Three studies were
judged as ‘high’ risk and five as ‘unclear’. Selective
reporting of results was judged as ‘low’ is six studies
and ‘high’ in one study. The remaining seventeen
studies were rated as ‘unclear’. Other bias was rated
as ‘low’ in eleven studies, compared to ‘high’ in eleven
of the studies. Two were rated as ‘unclear’. Eighteen
studies failed to reference a published protocol,
although there was little evidence of reporting bias.
We could not rule out potential researcher allegiance
in twelve studies, since many founders of specific
therapies evaluated their particular treatment model.
All studies presented objectives, but samples sizes
were often small.
3. Synthesis of results
Results of the meta-analyses are presented in Table 2
and the Forest plots (Figures 2–7). In summary, CBT-
TF/Exposure therapy was more effective at reducing
PTSD symptoms than waitlist/usual care post treat-
ment with the effect maintained at six months but
not at 12 months in the one study that explored this.
A review of the evidence in relation to specific CBT-
TF based interventions, PE was more effective than
waitlist at reducing PTSD symptoms post treatment
and at six months. CPT was more effective than
waitlist at reducing PTSD symptoms post treatment
but not at six months and leaving the study early was
more likely in the CPT arm. VRE was more effective
than waitlist at reducing PTSD symptoms post treat-
ment with leaving the study early was more likely in
the waitlist arm. Group CBT-TF was more effective
than waitlist at reducing PTSD symptoms post treat-
ment with leaving the study early more likely in the
waitlist arm. RTM was more effective than waitlist at
reducing PTSD symptoms post treatment with leav-
ing the study early more likely in the RTM arm.
There was no difference between Relaxation Training
and waitlist in reducing PTSD symptoms post treatment
or leaving the study early. There was no difference
between EMDR and waitlist in reducing PTSD symp-
toms post treatment or leaving the study early. Individual
CBT-TFwasmore effective thanGroupCBT-TF at redu-
cing PTSD symptoms post treatment but not maintained
at 6 months. CBT-TF was more effective than PCT in
reducing PTSD symptoms post treatment and at six
months. Leaving the study early also favoured the CBT-
TF arm.Therewas nodifference betweenGroupCBT-TF
and Group PCT in reducing PTSD symptoms post treat-
ment, but group CBT-TF was more effective at 6 and
12 months follow-up. Couples non-CBT-TF was more
effective than Couples Psychoeducation in reducing
PTSD symptoms post treatment and at 6 months follow-
up with no difference between the interventions on leav-
ing the study early.
There was no difference between EMDR and
Relaxation Training in reducing PTSD symptoms
post treatment, but the relaxation training arm was
more likely to leave the study early. There was no
difference between EMDR and REM-D in reducing
PTSD symptoms post treatment but leaving the study
early favoured the REM-D arm. There was no differ-
ence between VRE and PCT in reducing PTSD symp-
toms post treatment. Leaving the study early favoured
PCT. There was no difference between VRE and
Control Exposure in reducing PTSD symptoms post
treatment, at 6 or 12 months. Leaving the study early
favoured the VRE arm.
4. Heterogeneity
There was considerable clinical heterogeneity across the
psychological therapies aimed at reducing PTSD symp-
toms, which varied in content and delivery. Eighteen
studies included an intervention based on CBT-TF prin-
ciples, although the exact nature of what was included
varied from Implosive flooding therapy to CPT. The
method by which the psychological therapy delivered
also varied from several sessions delivered in the same
week, group therapy, couples therapy or wearing glasses
that playmusic during REM sleep. Duration of treatment
ranged from five sessions within one week to thirty
weekly sessions. Considerable statistical heterogeneity
was evident in all of the pooled comparisons resulting
in regular use of a random-effects model (see Table 2).
5. Clinical importance, quality of findings and
strength of recommendations
Using the ISTSS guidelines method to rate clinical
importance (ISTSS, 2018). CBT-TFs collectively had
an effect size which met our predetermined threshold
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of >0.80 or over for comparisons against waiting list
or TAU control. For specific interventions, only
Group CBT-TF and RTM met this threshold.
Similarly, for comparisons against an attention con-
trol intervention, only CBT-TF (vs. PCT) and couples
non-CBT-TF (vs couples psychoeducation) reached
>0.4 or above effect size (Foa et al., 2018; Rauch
et al., 2015; Schnurr et al., 2007; Suris et al., 2013),
and individual CBT-TF meets this threshold against
group CBT-TF from a single study (Resick et al.,
2017) against the active treatment comparisons and
reached >0.2 effect size or above. There were no
placebo control comparisons or single studies with
over 300 participants.
We used the GRADE system (GRADE, 2018) to
score each comparison, (see Table 2). Five compar-
isons were rated as Low quality, these included PE
(Foa et al., 2018; Nacasch et al., 2011; Reger et al.,
2016) vs. wait list, CBT-TF vs. waiting list (Foa et al.,
2018; Forbes et al., 2012; Gamito et al., 2010; Gray
et al., 2017; Keane et al., 1989; McLay et al., 2011;
Monson et al., 2006; Nacasch et al., 2011; Peniston &
Kulkosky, 1991; Reger et al., 2016; Tylee et al., 2017),
CBT-TF/Exposure (Foa et al., 2018; Rauch et al.,
2015; Schnurr et al., 2007; Suris et al., 2013)vs. PCT
and VRE vs. Control Exposure (McLay et al., 2017;
Reger et al., 2016), and Group CBT-TF vs. Group
Present Centred Therapy (Resick et al., 2017). All
other comparisons were rated as very low.
Using the ISTSS strength of recommendation algo-
rithm (Higgins et al., 2011), no psychological treat-
ments could be given a Strong recommendation.
CBT-TFs could be recommended at a Standard
level, with PE and CPT both being graded as inter-
ventions with Low Effect. CBT-TF, RTM and VRE
could be recommended as interventions with
Emerging Evidence of effect with there being insuffi-
cient evidence to recommend any other intervention.
6. Discussion
6.1. Main findings
Various forms of individual CBT-TF were the most
often tested and most effective psychological treat-
ments of PTSD in active duty and ex-serving military
personnel in this review. But no intervention could be
recommended strongly and only CBT-TF collectively
could be recommended at a standard level according
to the criteria used for the ISTSS Prevention and
Treatment Guidelines (ISTSS, 2018). The other thera-
pies tested could be recommended as interventions
with Low Effect or Emerging Evidence (CPT, Group
CBT-TF, PE, RTM and VRE) or with insufficient
evidence to recommend them (EMDR, Relaxation
Therapy, REM-D and PCT). Of the specific CBT-
TFs, CPT, Group CBT-TF, PE, RTM and VRE were
all effective when considered individually but only
Group CBT-TF and RTM met our predetermined
threshold for clinical importance (Gray et al., 2017;
Tylee et al., 2017). Despite Group CBT-TF being
more effective than waitlist and PCT, it was less
effective than individual CBT-TF. Of interest, effect
sizes in favour of PE and CPT over waiting list/usual
care were noticeably smaller than those obtained in
similar comparisons in studies of individuals seeking
treatment for non-military trauma (Lewis, et al in
preparation).
The UK’s NICE PTSD guidelines (2018) recom-
mended that people with combat-related PTSD
should not be treated with EMDR due to lack of
evidence for its effectiveness in this population
(NICE, 2018). Our results support this conclusion,
however, this is counter-intuitive given the prolifera-
tion of EMDR therapy used around the world and
non RCT evidence that it is successfully treating
PTSD related to active duty (Frappell-Cooke &
McCauley, 2018) and in ex-serving military personnel
(Kitchiner et al., 2012). This negative finding may be
real but may also be due to chance and several other
factors including small sample sizes leading to insuf-
ficient power, chronicity and treatment-resistance of
participants, and sub-optimal delivery of EMDR (two
studies reported novice EMDR therapists with only
level one training (2 days) (Carlson et al., 1998;
Jensen, 1994) and two studies offered only two
EMDR therapy sessions (Devilly et al., 1998; ISTSS,
2018; Jensen 1994; NICE, 2018). Twelve sessions of
EMDR were provided in Carlson’s 1998 study but the
control condition was biofeedback-assisted relaxation
which is an active control condition and the study
had several risks of bias. The two EMDR studies that
did report significant effects had sample sizes of only
23 (Ahmadi et al., 2015) and 25 (Jensen, 1994)
respectively. Jensen (1994) only offered two EMDR
sessions, and several risk of bias concerns were also
identified (Jensen, 1994); the outcome data should,
therefore, be treated with caution. More research is
clearly needed to determine whether or not EMDR is
effective for PTSD in this population.
Our results also support the UK’s NICE PTSD
guidelines (2018) recommendation that people with
combat-related PTSD be treated with CBT-TF. The
strength and quality of the evidence, however, is
relatively weak and using the algorithm developed
for the ISTSS Guidelines (ISTSS, 2018), no psycholo-
gical treatment could be recommended as strongly
for the treatment of combat-related PTSD as for
PTSD related to any traumatic event. There are
a number of possible reasons for this but the main
ones seem likely to be insufficient power due to the
low overall number of studies and, as previously
suggested, the possibility that people with combat-
related PTSD are more difficult to treat than people
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with PTSD related to other traumatic events
(Kitchiner et al., 2012; Steenkamp et al., 2015).
It is no surprise that the positive effect of CBT-TF
was significantly contributed to by PE and CPT
RCTs. More surprising, and encouraging, is the
emergence of new, innovative methods of delivery,
namely VRE and RMT. The RCTs of RMT, in parti-
cular, had very promising effect sizes and is worthy of
further exploration. There was evidence of greater
drop-out rates from CBT-TF studies compared to
waitlist and PCT (Steenkamp et al., 2015), although
this was primarily accounted for by greater drop-out
rates in PE RCTs; none of the other CBT-TFs were
associated with statistically significantly greater drop-
out rates than wait-list/usual care. Reasons for drop-
ping out will be multi-factorial, and may be due to
extended, repeated, and intense nature of deployment
trauma (Price, Gros, Strachan, Ruggiero, & Acierno,
2013) and service members being exposed to threats
to life and morally compromising experiences that
may require different treatment approaches (Litz
et al., 2009; Stein et al., 2012). However, the PE
finding is striking and suggests it may not be as well
tolerated as other forms of CBT-TF and that some
forms of CBT-TF may not be optimal and acceptable
to active duty and ex-service personnel in their cur-
rent format of delivery. Future research needs to gain
a better understanding of the reasons why individuals
drop out and experiment with novel ways to reduce
this. We were unable to identify any RCTs evaluating
third wave interventions such as Acceptance and
Commitment Therapy (ACT) or mindfulness based
therapy with serving or ex-serving personnel.
7. Strengths and limitations
This review rigorously followed guidelines set out by
the Cochrane Collaboration (Higgins et al., 2011).
Two authors independently screened the abstracts
identified by the literature search; read all potentially
relevant studies; assessed each study against the inclu-
sion criteria; extracted data from the written reports;
and rated each study for risk of bias. Any disagree-
ments were discussed with a third author, and unan-
imous decisions were reached for inclusion and
classification. Following these procedures minimized
the potential for bias, but some unavoidable issues
remained. Firstly, it is important to acknowledge the
possible influence of publication bias, since only pub-
lished papers were included in the review. In addi-
tion, this review relied only on English language
studies, which limits its generalizability.
Sample sizes were small in many studies. It can
therefore be argued that the absence of significant
differences in some comparisons represents a lack of
statistical power rather than true equivalence of the
approaches. The quality of individual studies is of
importance when interpreting the results of any
meta-analysis. Several of these studies were con-
ducted in the 1980/90s and deemed of poor quality
methodologically. Many of the included studies
demonstrated a lack of independent evaluation, as
thirteen of the studies were evaluated by the devel-
opers themselves. Participants were predominantly
male, white, had relatively low levels of education,
and many participants had experienced PTSD symp-
toms for over 30–40 years and would likely meet the
criteria for an ICD-11 diagnosis of Complex PTSD.
8. Clinical implications
This review demonstrates some evidence for indivi-
dual CBT-TF in the treatment of PTSD in active duty
and ex-serving personnel and that it should be
offered as the first line treatment. The US Veteran
Affairs (VA) department has invested and trained its
clinicians in two evidenced based psychological thera-
pies; PE (Foa, Rothbaum, Riggs, & Murdock, 1991)
and CPT (Resick, Nishith, Weaver, Astin, & Feuer,
2002). Our results tentatively support this decision
but, unfortunately, despite a national rollout of train-
ing and supervision, there is evidence that PE and
CPT are rarely used in VA clinics, resulting in non-
trauma focused therapies still being offered to active
duty and ex-service personnel (Shiner et al., 2013).
This points to the need for more effective dissemina-
tion and implementation of the best evidenced treat-
ments for PTSD and more effective treatments for
combat-related PTSD.
It is too early to argue that VRE and RTM should
become first-line treatments ahead of, or be considered
equivalent to, PE and CPT. The emerging evidence of
their efficacy, however, along with some concerns about
the acceptability of PE and the minimal imaginal expo-
sure involved in RTM should encourage more work to
determine whether they should be seen as valid alterna-
tives to more established paradigms. If individuals have
difficulty engaging in standard CBT-TF, alternative
forms of delivery could also be considered. For example,
intensive CBT-TF with multiple sessions weekly, for
active duty personnel may improve uptake due to the
short time away from normal duties (Foa et al., 2018).
The finding of some support for group CBT-TF is
encouraging, but as it is not as effective as individual
therapy it should not be considered first line at present.
The lack of evidence of effect for EMDR should preclude
its routine, first-line use in this population. However,
given the quality of the current RCT evidence in this
population and the evidence from other sources, it
would not be unreasonable to consider EMDR in indivi-
duals who do not respond to CBT-TF or are unable to
tolerate it. Non trauma focused psychological therapies
such as PCT could be offered as an alternative to CBT-TF
in treatment seeking active duty and ex-serving personnel
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who do not wish to engage in trauma-focused therapies,
or to those who are unable to tolerate them (Foa et al.,
2018).
It is important to remember that the complexity of
a person with PTSD’s biopsychosocial symptoms at
presentation may also be a factor that inhibits
a reduction in PTSD and other co-morbid symptoms.
There continues to be considerable challenges for
health care systems who provide mental health treat-
ment to active duty and ex-serving military personnel
to find efficient ways to train personnel, promote and
disseminate effective treatments for PTSD (Schnurr
et al., 2007) and also to provide a holistic approach to
care that takes social factors, in particular, into
account. Careful monitoring is required to make
sure that future TFPTs that improve symptoms of
PTSD also improve the overall health and lives of
active duty and ex-serving military personnel
(McLay et al., 2011).
9. Research implications
Despite over 40 years of research focused on reducing
PTSD in active duty and ex-serving military personnel,
effect sizes and acceptability of current therapies remain
modest although, as described above, advances have been
made and the evidence is more robust than it was when
we last reviewed the literature in 2012. Future RCTs
should adopt rigorous methodological designs, including
more adequately powered, pragmatic effectiveness phase
III studies. Other key areas for future research include:
replication of the finding that intensive PE is non-inferior
to the standard weekly protocol (Foa et al., 2018) and
research into briefer delivery of other interventions;
methods to reduce drop out rates and better explore
acceptability; why the results for EMDR appear to be
different in this population than other populations;
whether there are differences between responses of active
duty and ex-service personnel; whether there are differ-
ences between those with a diagnosis of PTSD and those
with a diagnosis of complex PTSD; and how well treat-
ment gains are maintained with follow-up periods of
longer than 6–12 months (Monson et al., 2006).
Treatments with emerging evidence of efficacy
such as VRE and RTM deserve more attention and
future studies of TFPT should consider adding inter-
personal skill training components and other techni-
ques to address the core components of complex
PTSD (Cloitre et al., 2010). Broadening the base of
countries and cultures in which treatments are tested
will be necessary to increase the confidence that such
treatments can be applied globally by therapists with
no model specific allegiance (Forbes et al., 2012).
More research is required to develop and investigate
novel therapies (Ahmadi et al., 2015), and improve
our understanding of cognitive and biological
mechanisms of PTSD treatment to help refine
treatments and increase rates of response (Rauch
et al., 2015).
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